ES340334A1 - Procedimiento para la produccion de bis-(p-clorofenoxi) a- cetatos. - Google Patents
Procedimiento para la produccion de bis-(p-clorofenoxi) a- cetatos.Info
- Publication number
- ES340334A1 ES340334A1 ES340334A ES340334A ES340334A1 ES 340334 A1 ES340334 A1 ES 340334A1 ES 340334 A ES340334 A ES 340334A ES 340334 A ES340334 A ES 340334A ES 340334 A1 ES340334 A1 ES 340334A1
- Authority
- ES
- Spain
- Prior art keywords
- chlorophenoxy
- general formula
- radical
- bis
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000006243 chemical reaction Methods 0.000 abstract 7
- -1 pyrrolidino, piperidino, morpholino Chemical group 0.000 abstract 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 3
- 150000003254 radicals Chemical group 0.000 abstract 3
- ZKNSZZXBPSICFK-UHFFFAOYSA-N 2,2-bis(4-chlorophenoxy)acetic acid Chemical class C=1C=C(Cl)C=CC=1OC(C(=O)O)OC1=CC=C(Cl)C=C1 ZKNSZZXBPSICFK-UHFFFAOYSA-N 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 2
- HDOWRFHMPULYOA-UHFFFAOYSA-N piperidin-4-ol Chemical compound OC1CCNCC1 HDOWRFHMPULYOA-UHFFFAOYSA-N 0.000 abstract 2
- 125000001453 quaternary ammonium group Chemical group 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- YEYZALQTJCVXIJ-HXUWFJFHSA-N (2R)-2-amino-2-(methoxymethyl)-4-(4-octylphenyl)butan-1-ol Chemical compound CCCCCCCCC1=CC=C(CC[C@@](N)(CO)COC)C=C1 YEYZALQTJCVXIJ-HXUWFJFHSA-N 0.000 abstract 1
- CEUZTHSDJADUSJ-UHFFFAOYSA-N 1-prop-2-ynylpiperidin-4-ol Chemical compound OC1CCN(CC#C)CC1 CEUZTHSDJADUSJ-UHFFFAOYSA-N 0.000 abstract 1
- 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 abstract 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 abstract 1
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical compound [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 229910052783 alkali metal Inorganic materials 0.000 abstract 1
- 150000001340 alkali metals Chemical class 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000002490 anilino group Chemical group [H]N(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 abstract 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical group BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 abstract 1
- 229910052794 bromium Chemical group 0.000 abstract 1
- 229910052801 chlorine Inorganic materials 0.000 abstract 1
- 239000000460 chlorine Substances 0.000 abstract 1
- 125000001309 chloro group Chemical group Cl* 0.000 abstract 1
- 125000004663 dialkyl amino group Chemical group 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 230000000055 hyoplipidemic effect Effects 0.000 abstract 1
- 230000000871 hypocholesterolemic effect Effects 0.000 abstract 1
- YVPXTMQZKPQMAF-UHFFFAOYSA-N methyl 2,2-bis(4-chlorophenoxy)acetate Chemical compound COC(C(OC1=CC=C(C=C1)Cl)OC1=CC=C(C=C1)Cl)=O YVPXTMQZKPQMAF-UHFFFAOYSA-N 0.000 abstract 1
- HKMLRUAPIDAGIE-UHFFFAOYSA-N methyl 2,2-dichloroacetate Chemical compound COC(=O)C(Cl)Cl HKMLRUAPIDAGIE-UHFFFAOYSA-N 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- YORCIIVHUBAYBQ-UHFFFAOYSA-N propargyl bromide Chemical compound BrCC#C YORCIIVHUBAYBQ-UHFFFAOYSA-N 0.000 abstract 1
- CFPLEOLETMZLIB-UHFFFAOYSA-M sodium;4-chlorophenolate Chemical compound [Na+].[O-]C1=CC=C(Cl)C=C1 CFPLEOLETMZLIB-UHFFFAOYSA-M 0.000 abstract 1
- NQRYJNQNLNOLGT-UHFFFAOYSA-N tetrahydropyridine hydrochloride Natural products C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/12—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US54947566A | 1966-05-12 | 1966-05-12 | |
| US56875966A | 1966-07-29 | 1966-07-29 | |
| US59897066A | 1966-12-05 | 1966-12-05 | |
| US61532167A | 1967-02-13 | 1967-02-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES340334A1 true ES340334A1 (es) | 1968-06-01 |
Family
ID=27504740
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES340334A Expired ES340334A1 (es) | 1966-05-12 | 1967-05-10 | Procedimiento para la produccion de bis-(p-clorofenoxi) a- cetatos. |
| ES345156A Expired ES345156A1 (es) | 1966-05-12 | 1967-09-18 | Procedimiento para la produccion de bis-(p-clorofenoxi) acetatos. |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES345156A Expired ES345156A1 (es) | 1966-05-12 | 1967-09-18 | Procedimiento para la produccion de bis-(p-clorofenoxi) acetatos. |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US3534051A (es) |
| AT (3) | AT294056B (es) |
| BE (1) | BE698303A (es) |
| CH (1) | CH482644A (es) |
| CY (1) | CY687A (es) |
| DE (1) | DE1695723A1 (es) |
| DK (1) | DK119562B (es) |
| ES (2) | ES340334A1 (es) |
| FI (1) | FI46499C (es) |
| FR (1) | FR7147M (es) |
| GB (2) | GB1188109A (es) |
| MY (1) | MY7300317A (es) |
| NL (4) | NL142401B (es) |
| SE (1) | SE334882B (es) |
-
1967
- 1967-02-13 US US615321A patent/US3534051A/en not_active Expired - Lifetime
- 1967-04-20 CH CH567767A patent/CH482644A/de not_active IP Right Cessation
- 1967-04-24 GB GB49342/69A patent/GB1188109A/en not_active Expired
- 1967-04-24 GB GB08833/67A patent/GB1187501A/en not_active Expired
- 1967-05-05 NL NL676706300A patent/NL142401B/xx unknown
- 1967-05-10 AT AT960268A patent/AT294056B/de not_active IP Right Cessation
- 1967-05-10 FI FI671346A patent/FI46499C/fi active
- 1967-05-10 BE BE698303D patent/BE698303A/xx unknown
- 1967-05-10 AT AT960368A patent/AT294057B/de not_active IP Right Cessation
- 1967-05-10 DK DK245867AA patent/DK119562B/da unknown
- 1967-05-10 ES ES340334A patent/ES340334A1/es not_active Expired
- 1967-05-10 AT AT437467A patent/AT289770B/de not_active IP Right Cessation
- 1967-05-10 DE DE19671695723 patent/DE1695723A1/de active Pending
- 1967-05-11 SE SE06610/67A patent/SE334882B/xx unknown
- 1967-08-08 FR FR117186A patent/FR7147M/fr not_active Expired
- 1967-09-18 ES ES345156A patent/ES345156A1/es not_active Expired
-
1973
- 1973-06-04 CY CY68773A patent/CY687A/xx unknown
- 1973-12-31 MY MY1973317A patent/MY7300317A/xx unknown
-
1974
- 1974-04-17 NL NL7405178A patent/NL7405178A/xx unknown
- 1974-04-17 NL NL7405179A patent/NL7405179A/xx unknown
- 1974-04-17 NL NL7405180A patent/NL7405180A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK119562B (da) | 1971-01-25 |
| AT289770B (de) | 1971-05-10 |
| GB1187501A (en) | 1970-04-08 |
| NL6706300A (es) | 1967-11-13 |
| SE334882B (es) | 1971-05-10 |
| FI46499C (fi) | 1973-04-10 |
| US3534051A (en) | 1970-10-13 |
| ES345156A1 (es) | 1969-01-16 |
| AT294057B (de) | 1971-11-10 |
| GB1188109A (en) | 1970-04-15 |
| CH482644A (de) | 1969-12-15 |
| FR7147M (es) | 1969-08-04 |
| MY7300317A (en) | 1973-12-31 |
| NL7405178A (es) | 1974-06-25 |
| NL7405180A (es) | 1974-06-25 |
| BE698303A (es) | 1967-11-10 |
| DE1695723A1 (de) | 1972-03-02 |
| AT294056B (de) | 1971-11-10 |
| NL7405179A (es) | 1974-06-25 |
| FI46499B (fi) | 1973-01-02 |
| NL142401B (nl) | 1974-06-17 |
| CY687A (en) | 1973-06-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES377906A1 (es) | Procedimiento de preparacion de nuevos derivados tricicli- cos. | |
| GB1062714A (en) | -ß-(4'-acyloxy-4'-piperidyl)-ketones | |
| ES380859A1 (es) | Un procedimiento para la preparacion de derivados de diben-zo-dioxocin. | |
| ES340334A1 (es) | Procedimiento para la produccion de bis-(p-clorofenoxi) a- cetatos. | |
| GB1171670A (en) | Derivatives of 4-Aryl-3-Hydroxybutyric Acid | |
| ES345835A1 (es) | Procedimiento para la preparacion de nuevas fenilacetami- das. | |
| ES339432A1 (es) | Un procedimiento para la obtencion de nuevas tetrahidro- quinazolinas sustituidas por halogenos. | |
| ES337591A1 (es) | Procedimiento de obtencion de acidos acrilicos transusti- tuidos y sus sales, de efecto coleretico. | |
| ES481855A1 (es) | Procedimiento para la preparacion de nuevos revidados de 6- metoxi-2-acetilnaftaleno oxima con actividad analgesica. | |
| GB1111361A (en) | 4-phenoxyalkanoic acids and derivatives thereof | |
| GB1085066A (en) | Substituted alkylpiperidines and methods of preparation thereof | |
| GB1245155A (en) | NOVEL 5-SUBSTITUTED-gamma-CARBOLINE DERIVATIVES AND THE SALTS THEREOF | |
| US3821248A (en) | Bis-(p-chlorphenoxy)acetic acid esters | |
| ES365518A1 (es) | Procedimiento para la preparacion de derivados del acido a-cetico. | |
| GB1351526A (en) | Tropan-3-ol derivatives and processes for their preparation | |
| GB1195319A (en) | Alkyl Sulfate Salts of 1-(p-Chlorobenzhydryl)-4-Methylhomopiperazines | |
| ES350475A1 (es) | Procedimiento para la preparacion de esteres basicos con actividad cardiovascular. | |
| ES355551A1 (es) | Procedimiento para la preparacion de derivados de piperidi-na. | |
| ES8307233A1 (es) | Procedimiento para preparar derivados del acido 1,4-tiazan-3-carboxilico. | |
| GB1244881A (en) | New piperidine derivatives, process for their production and preparations containing same | |
| GB1164496A (en) | 0-Oxaphenanthridine Derivatives and Method for the Preparation | |
| ES306443A1 (es) | Procedimiento de preparaciën de derivados de quinoleina | |
| GB1211387A (en) | 0-benzylpiperidine derivative and a process for the preparation thereof | |
| GB1054291A (es) | ||
| GB1282405A (en) | Piperidine spiro compounds and pharmaceutical preparations thereof |